| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Executive Officer | 10% Owner | Chief Executive Officer
2 companies
Smith Patrick W is a 10% Owner at Insight Molecular Diagnostics Inc. with holdings across 2 companies. Recent SEC Form 4 filings include 3 buys and 134 sells.
Estimated insider holdings value: $1334.8M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 9, 2026 | AXON Axon Enterprise, Inc. | Chief Executive Officer | Sell | 10,000 | $560.24 | $5,602,393.87 | - | - | - | |
| Jan 7, 2026 | Chief Executive Officer | Sell | 10,000 | $619.01 | $6,190,145.61 | - | -39.9% | - | ||
| Dec 8, 2025 | Chief Executive Officer | Sell | 10,000 | $551.92 | $5,519,164.10 | - | +1.1% | - | ||
| Nov 7, 2025 | Chief Executive Officer | Sell | 10,957 | $589.72 | $6,461,559.96 | - | -33.7% | - | ||
| Oct 7, 2025 | Chief Executive Officer | Sell | 10,000 | $713.74 | $7,137,352.62 | - | -17.3% | - | ||
| Sep 8, 2025 | Chief Executive Officer | Sell | 10,000 | $743.64 | $7,436,415.19 | - | -25.3% | - | ||
| Aug 11, 2025 | Chief Executive Officer | Sell | 10,000 | $831.29 | $8,312,886.46 | - | -28.6% | - | ||
| Apr 21, 2025 | Chief Executive Officer | Sell | 10,000 | $540.99 | $5,409,861.26 | - | +38.7% | - | ||
| Feb 7, 2025 | IMDX Insight Molecular Diagnostics Inc. | 10% Owner | Buy | 1,077,600 | $2.05 | $2,209,080.00 | +60.0% | +41.3% | +264.2% | |
| Feb 4, 2025 | IMDX Insight Molecular Diagnostics Inc. | 10% Owner | Buy | 915 | $2.01 | $1,839.40 | - | +37.1% | +211.7% |